Skip to main content

Volume 3 Supplement 1

Abstracts of the Breast Cancer Immunotherapy Symposium (BRECIS): Sidra Symposia Series

  • Poster presentation
  • Open access
  • Published:

Carbon nanomaterials as contrast agents for breast cancer diagnosis and therapy

Nanotechnology is the promise to fight breast cancer (BC) more specifically and effectively [1]. In this context carbon nanomaterials (CNs) have attracted the scientific community and the public interest [2]. Common modalities for BC diagnosis are ultrasonography (US) and magnetic resonance imaging (MRI). US is the most useful modality in the evaluation of palpable BC masses that are mammographically occult in women younger than 30’s. Here we show CNs as highly and long lasting echogenic materials. Experiments on swine models confirmed that CNs are clearly visible under US and didn’t exert toxicity. In the current market dual-imaging agents are missed; here we also demonstrate the immune-compatibility and high echogenic properties in water and in whole blood of cysteine functionalized super paramagnetic nanoparticles (CY-SPION), well-known MRI agents [3]. Thanks to these findings, and the ability to load CNs to many moieties [46], we propose dual-contrast agents, CNs-CY-SPION conjugates, to improve BC diagnosis. Future perspectives is to conjugate CN-SPION to targeted drugs against BC. In summary, we lay the foundations for novel contrast agents, for therapy and multimodal diagnosis of BC, combining high imaging performances with unique potential therapeutic applications, such as specific targeting capabilities, drug delivery, immunotherapy and hyperthermia.


  1. Avitabile E, Bedognetti D, Sgarella F, Delogu LG: Nanotechnology fight for breast cancer. (under preparation)

  2. Sechi G, Bedognetti D, Sgarrella F, Van Eperen, L, Marincola FM, Bianco A, Delogu LG: The perception of nanotechnology and nanomedicine: a worldwide social media study. Nanomedicine. 2014, 9 (10): 1475-86. 10.2217/nnm.14.78.

    Article  CAS  PubMed  Google Scholar 

  3. Dolci A, Ierardic V, Gradi A, Jagli Z, Remskard M, Apihd T, Cifellia M, Pampalonia G, Veracinia CA, Domenici V: Precursors of Magnetic Resonance Imaging Contrast Agents Based on Cystine-coated Iron-oxide Nanoparticles. Current Physical Chemistry. 2013, 3 (4): 493-500. 10.2174/18779468113036660009.

    Article  CAS  Google Scholar 

  4. Delogu LG, Magrini A, Bergamaschi A, Rosato N, Dawson MI, Bottini N: Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug Chem. 2009, 18 (20): 427-431. 10.1021/bc800540j.

    Article  Google Scholar 

  5. Delogu LG, Venturelli E, Manetti R, Pinna GA, Carru C, Madeddu R, Murgia L, Sgarrella F, Dumortier H, Bianco A: Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond). 2012, 7 (2): 231-243. 10.2217/nnm.11.101.

    Article  CAS  Google Scholar 

  6. Modugno G, Ménard-Moyon C, Prato M, Bianco A: Carbon nanomaterials combined with metal nanoparticles for theranostic applications. Br J Pharmacol. 2015, 172 (4): 975-91. 10.1111/bph.12984.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolci, S., Domenici, V., Vidili, G. et al. Carbon nanomaterials as contrast agents for breast cancer diagnosis and therapy. j. immunotherapy cancer 3 (Suppl 1), P5 (2015).

Download citation

  • Published:

  • DOI: